Payment overview · 2025
General Payments
$45.00
1 reported records · 1 companies
Healthcare provider profile · identity verified
Dennis Eugene Robinson, D.O.
Allopathic & Osteopathic Physicians|Family Medicine · MARSHFIELD, MO · NPI 1295712743
Verified facts
What the public records show
CMS Open Payments records show Dennis Eugene Robinson, D.O. received $45.00 in general payments during 2025 across 1 reported records.
Lilly USA, LLC accounted for 100.0% of that reported general-payment amount.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 18 claims for Jardiance by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 17 claims for Mounjaro by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $45.00 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Education | $45.00 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
Payment records were found, but the reported records did not identify a specific associated product for this analysis.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
18 | suppressed by CMS |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | MOUNJARO open payments reported associated product |
CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455 |
Mounjaro · 2024 Exact normalized brand match · 1 Part D row |
17 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 1351 | 328 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 963 | 167 |
| Alprazolam | Alprazolam | 877 | 157 |
| Atorvastatin Calcium | Atorvastatin Calcium | 784 | 201 |
| Lisinopril | Lisinopril | 696 | 192 |
| Losartan Potassium | Losartan Potassium | 589 | 164 |
| Gabapentin | Gabapentin | 540 | 137 |
| Amlodipine Besylate | Amlodipine Besylate | 500 | 143 |
| Metoprolol Succinate | Metoprolol Succinate | 494 | 127 |
| Pantoprazole Sodium | Pantoprazole Sodium | 486 | 134 |
| Potassium Chloride | Potassium Chloride | 467 | 148 |
| Omeprazole | Omeprazole | 383 | 100 |
| Meloxicam | Meloxicam | 376 | 87 |
| Trazodone Hcl | Trazodone Hcl | 376 | 74 |
| Furosemide | Furosemide | 359 | 104 |
| Metformin Hcl | Metformin Hcl | 354 | 91 |
| Simvastatin | Simvastatin | 332 | 88 |
| Eliquis | Apixaban | 326 | 52 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 325 | 86 |
| Tamsulosin Hcl | Tamsulosin Hcl | 320 | 94 |
| Allopurinol | Allopurinol | 266 | 80 |
| Hydrochlorothiazide | Hydrochlorothiazide | 255 | 73 |
| Tramadol Hcl | Tramadol Hcl | 251 | 65 |
| Tizanidine Hcl | Tizanidine Hcl | 231 | 56 |
| Azithromycin | Azithromycin | 208 | 157 |
| Zolpidem Tartrate | Zolpidem Tartrate | 203 | 32 |
| Clonazepam | Clonazepam | 202 | 38 |
| Celecoxib | Celecoxib | 199 | 55 |
| Metformin Hcl Er | Metformin Hcl | 195 | 61 |
| Bupropion Xl | Bupropion Hcl | 192 | 42 |
| Doxycycline Hyclate | Doxycycline Hyclate | 191 | 148 |
| Donepezil Hcl | Donepezil Hcl | 184 | 51 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 181 | 29 |
| Sertraline Hcl | Sertraline Hcl | 179 | 42 |
| Estradiol | Estradiol | 174 | 54 |
| Escitalopram Oxalate | Escitalopram Oxalate | 172 | 42 |
| Temazepam | Temazepam | 171 | 33 |
| Metoprolol Tartrate | Metoprolol Tartrate | 167 | 47 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 152 | 108 |
| Ozempic | Semaglutide | 147 | 31 |
| Glimepiride | Glimepiride | 143 | 37 |
| Ropinirole Hcl | Ropinirole Hcl | 138 | 32 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 133 | 33 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 124 | 30 |
| Clopidogrel | Clopidogrel Bisulfate | 118 | 30 |
| Lorazepam | Lorazepam | 117 | 22 |
| Carvedilol | Carvedilol | 114 | 29 |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 112 | 23 |
| Fluconazole | Fluconazole | 112 | 67 |
| Fluticasone Propionate | Fluticasone Propionate | 108 | 31 |
| Pregabalin | Pregabalin | 103 | 17 |
| Oxycodone Hcl | Oxycodone Hcl | 101 | 12 |
| Chlorthalidone | Chlorthalidone | 99 | 26 |
| Amoxicillin | Amoxicillin | 98 | 79 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 95 | 30 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 94 | 28 |
| Oxybutynin Chloride | Oxybutynin Chloride | 93 | 24 |
| Fenofibrate | Fenofibrate | 89 | 17 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 87 | 26 |
| Finasteride | Finasteride | 85 | 24 |
| Colestipol Hcl | Colestipol Hcl | 80 | 23 |
| Ondansetron Odt | Ondansetron | 80 | 47 |
| Prednisone | Prednisone | 77 | 44 |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 76 | 21 |
| Citalopram Hbr | Citalopram Hydrobromide | 73 | 20 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 73 | 15 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 72 | 22 |
| Acarbose | Acarbose | 71 | 28 |
| Primidone | Primidone | 69 | 12 |
| Fluoxetine Hcl | Fluoxetine Hcl | 67 | 14 |
| Xarelto | Rivaroxaban | 67 | 13 |
| Warfarin Sodium | Warfarin Sodium | 66 | 18 |
| Buprenorphine Hcl | Buprenorphine Hcl | 64 | 14 |
| Atenolol | Atenolol | 61 | 17 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 61 | 39 |
| Cefdinir | Cefdinir | 59 | 39 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 58 | 15 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 57 | 47 |
| Memantine Hcl | Memantine Hcl | 54 | 13 |
| Mupirocin | Mupirocin | 54 | 37 |
| Mirtazapine | Mirtazapine | 53 | 13 |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 53 | 40 |
| Acyclovir | Acyclovir | 51 | 30 |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 51 | 22 |
| Diclofenac Sodium | Diclofenac Sodium | 50 | 14 |
| Farxiga | Dapagliflozin Propanediol | 50 | suppressed |
| Diazepam | Diazepam | 49 | 15 |
| Duloxetine Hcl | Duloxetine Hcl | 49 | 13 |
| Levofloxacin | Levofloxacin | 49 | 43 |
| Famotidine | Famotidine | 48 | 18 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 47 | 15 |
| Testosterone Cypionate | Testosterone Cypionate | 47 | 14 |
| Pravastatin Sodium | Pravastatin Sodium | 45 | 12 |
| Clonidine Hcl | Clonidine Hcl | 44 | 12 |
| Alendronate Sodium | Alendronate Sodium | 43 | 11 |
| Paroxetine Hcl | Paroxetine Hcl | 43 | suppressed |
| Valsartan | Valsartan | 43 | 12 |
| Meclizine Hcl | Meclizine Hcl | 42 | 25 |
| Naproxen | Naproxen | 42 | suppressed |
| Ibuprofen | Ibuprofen | 41 | 16 |
| Montelukast Sodium | Montelukast Sodium | 41 | 13 |
| Lovastatin | Lovastatin | 40 | 12 |
| Spironolactone | Spironolactone | 40 | 14 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 40 | suppressed |
| Cilostazol | Cilostazol | 38 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 38 | suppressed |
| Progesterone | Progesterone, Micronized | 38 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 37 | suppressed |
| Ezetimibe | Ezetimibe | 37 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 37 | 12 |
| Symbicort | Budesonide/Formoterol Fumarate | 37 | suppressed |
| Januvia | Sitagliptin Phosphate | 36 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 36 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 35 | 29 |
| Azelastine Hcl | Azelastine Hcl | 34 | 16 |
| Propranolol Hcl | Propranolol Hcl | 34 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 33 | 29 |
| Hydrocortisone | Hydrocortisone | 33 | 14 |
| Methocarbamol | Methocarbamol | 33 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 33 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 32 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 32 | suppressed |
| Entresto | Sacubitril/Valsartan | 32 | suppressed |
| Tiadylt Er | Diltiazem Hcl | 32 | 12 |
| Benazepril Hcl | Benazepril Hcl | 31 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 31 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 31 | 16 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 31 | 11 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 31 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 31 | suppressed |
| Cephalexin | Cephalexin | 30 | 27 |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 30 | suppressed |
| Glipizide | Glipizide | 30 | 11 |
| Glipizide Er | Glipizide | 30 | 11 |
| Nitroglycerin | Nitroglycerin | 30 | 25 |
| Ketoconazole | Ketoconazole | 29 | 16 |
| Methotrexate | Methotrexate Sodium | 29 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 28 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 28 | 21 |
| Synthroid | Levothyroxine Sodium | 28 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 27 | suppressed |
| Nifedipine Er | Nifedipine | 27 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 27 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 26 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 26 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 26 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 26 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 25 | suppressed |
| Topiramate | Topiramate | 25 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 24 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 24 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 24 | suppressed |
| Aripiprazole | Aripiprazole | 23 | suppressed |
| Lansoprazole | Lansoprazole | 23 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 23 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 23 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 23 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 22 | 13 |
| Levetiracetam | Levetiracetam | 21 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 21 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 21 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 20 | suppressed |
| Klor-Con M20 | Potassium Chloride | 20 | suppressed |
| Methadone Hcl | Methadone Hcl | 20 | suppressed |
| Torsemide | Torsemide | 20 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 20 | suppressed |
| Np Thyroid | Thyroid,pork | 19 | suppressed |
| Vilazodone Hcl | Vilazodone Hcl | 19 | suppressed |
| Carisoprodol | Carisoprodol | 18 | suppressed |
| Colchicine | Colchicine | 18 | 11 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 18 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 18 | suppressed |
| Jardiance | Empagliflozin | 18 | suppressed |
| Metronidazole | Metronidazole | 18 | 16 |
| Verapamil Er | Verapamil Hcl | 18 | suppressed |
| Bumetanide | Bumetanide | 17 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 17 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 17 | suppressed |
| Linzess | Linaclotide | 17 | suppressed |
| Mounjaro | Tirzepatide | 17 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 17 | suppressed |
| Rybelsus | Semaglutide | 17 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 17 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 17 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 16 | 16 |
| Modafinil | Modafinil | 16 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 16 | 16 |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 15 | 14 |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 15 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 15 | suppressed |
| Novolog Flexpen | Insulin Aspart | 15 | suppressed |
| Nystatin | Nystatin | 15 | suppressed |
| Risperidone | Risperidone | 15 | suppressed |
| Clotrimazole | Clotrimazole | 14 | 14 |
| Euthyrox | Levothyroxine Sodium | 14 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 14 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 13 | suppressed |
| Atomoxetine Hcl | Atomoxetine Hcl | 13 | suppressed |
| Dilantin | Phenytoin Sodium Extended | 13 | suppressed |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 13 | suppressed |
| Imipramine Hcl | Imipramine Hcl | 13 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 13 | suppressed |
| Roflumilast | Roflumilast | 13 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 13 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Chlordiazepoxide Hcl | Chlordiazepoxide Hcl | 12 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 12 | suppressed |
| Lidocaine | Lidocaine | 12 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 12 | suppressed |
| Sulfasalazine | Sulfasalazine | 12 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 12 | suppressed |
| Zubsolv | Buprenorphine Hcl/Naloxone Hcl | 12 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 11 | suppressed |
| Digoxin | Digoxin | 11 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 11 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 11 | suppressed |
| Metolazone | Metolazone | 11 | suppressed |
| Novolin N | Insulin Nph Human Isophane | 11 | suppressed |
| Tradjenta | Linagliptin | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $45.00 · 1 records | Lilly USA, LLC | — | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with Lilly USA, LLC?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error